References
- G.Garcia-TsaoA.J.SanyalN.D.GraceW.CareyPrevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosisHepatology (Baltimore, Md).462007922938
- G.D'AmicoR.De FranchisUpper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicatorsHepatology (Baltimore, Md).382003599612
- R.de FranchisRevising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertensionJ Hepatol532010762768
- R.de FranchisEvolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertensionJ Hepatol432005167176
- E.SchwarzenbergerT.MeyerV.GollaN.P.SahdalaA.D.MinUtilization of platelet count spleen diameter ratio in predicting the presence of esophageal varices in patients with cirrhosisJ Clin Gastroenterol442010146150
- A.SarangapaniC.ShanmugamM.KalyanasundaramB.RangachariP.ThangaveluJ.K.SubbarayanNoninvasive prediction of large esophageal varices in chronic liver disease patientsSaudi J Gastroenterol: Off J Saudi Gastroenterol Assoc1620103842
- L.K.WeaverK.A.Hintz-GoldsteinP.A.PioliPivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163J Leukocyte Biol8020062635
- S.K.MoestrupH.J.MollerCD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory responseAnn Med362004347354
- A.EtzerodtM.B.ManieckiK.MollerH.J.MollerS.K.MoestrupTumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163J Leukocyte Biol88201012011205
- D.J.SchaerB.SchleiffenbaumM.KurrerSoluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndromeEur J Haematol742005610
- A.HiraokaN.HoriikeS.M.AkbarK.MichitakaT.MatsuyamaM.OnjiExpression of CD163 in the liver of patients with viral hepatitisPathol Res Pract2012005379384
- A.HiraokaN.HoriikeS.M.F.AkbarK.MichitakaT.MatsuyamaM.OnjiSoluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failureJ Gastroenterol4020055256
- H.J.MollerH.GronbaekF.V.SchiodtSoluble CD163 from activated macrophages predicts mortality in acute liver failureJ Hepatol472007671676
- P.Holland-FischerH.GronbaekT.D.SandahlKupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPSGut60201113891393
- A.Loaeza-del-CastilloF.Paz-PinedaE.Oviedo-CardenasF.Sanchez-AvilaF.Vargas-VorackovaAST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosisAnn Hepatol72008350357
- A.Vallet-PichardV.MalletB.NalpasFIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestHepatology (Baltimore, Md).4620073236
- S.BotaR.SirliI.SporeaA new scoring system for prediction of fibrosis in chronic hepatitis CHepatitis Monthly112011548555
- K.C.ThomopoulosC.Labropoulou-KaratzaK.P.MimidisE.C.KatsakoulisG.IconomouV.N.NikolopoulouNon-invasive predictors of the presence of large oesophageal varices in patients with cirrhosisDigest Liver Dis: Off J Ital Soc Gastroenterol Ital Assoc Study Liver352003473478
- E.GianniniD.RissoF.BottaValidity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver diseaseArch Intern Med16322003218224
- C.-T.WaiJ.K.GreensonR.J.FontanaA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology (Baltimore, Md).382003518526
- E.G.GianniniA.ZamanA.KreilPlatelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation studyAm J Gastroenterol101200625112519
- T.AlempijevicV.BulatS.DjuranovicRight liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertensionWorld J Gastroenterol: WJG13200753315335
- L.CasteraM.PinzaniJ.BoschNon invasive evaluation of portal hypertension using transient elastographyJ Hepatol562012696703
- X.FornsS.AmpurdanesJ.M.LlovetIdentification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modelHepatology (Baltimore, Md).362002986992
- A.S.F.LokM.G.GhanyZ.D.GoodmanPredicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohortHepatology (Baltimore, Md).422005282292
- C.CammaS.PettaV.Di MarcoInsulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosisHepatology (Baltimore, Md).492009195203
- D.M.TorresS.A.HarrisonInsulin resistance in chronic hepatitis C, genotypes 1 and 4: the unfortunate realityHepatology (Baltimore, Md).47200821372139
- M.EslamJ.AmpueroM.JoverPredicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variablesAnn Hepatol122013588598
- G.SebastianiD.TempestaG.FattovichPrediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale studyJ Hepatol532010630638
- H.StefanescuM.GrigorescuM.LupsorA new and simple algorithm for the noninvasive assessment of esophageal varices in cirrhotic patients using serum fibrosis markers and transient elastographyJ Gastr Liver Dis: JGLD2020115764
- E.M.HassanD.A.OmranM.L.El BeshlaweyM.AbdoA.El AskaryCan transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients?Gastroenterol Hepatol3720145865
- M.ShehataL.AboAliK.El-ShafeyM.El-HossaryA comparative study of Duplex Doppler ultrasound and blood indices as noninvasive predictors of oesophageal varices in cirrhotic patientsTanta Med J4220148391
- L.CasteraB.Le BailF.Roudot-ThoravalEarly detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scoresJ Hepatol5020095968
- J.R.TafarelL.H.TolentinoL.M.CorreaPrediction of esophageal varices in hepatic cirrhosis by noninvasive markersEur J Gastroenterol Hepatol232011754758
- M.R.AdamiC.T.FerreiraC.O.KielingV.HirakataS.M.G.VieiraNoninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertensionWorld J Gastroenterol: WJG19201320532059
- Ghada M.Galal AagEman M.S.MuhammadLaila M.YousefClinical utility of simple fibrosis markers in prediction of oesophageal varices in chronic hepatitis C patients with advanced fibrosisMed J Cairo Univ8020128593
- H.NyblomE.BjornssonM.SimrenF.AldenborgS.AlmerR.OlssonThe AST/ALT ratio as an indicator of cirrhosis in patients with PBCLiver Int: Off J Int Assoc Study Liver262006840845
- S.TreeprasertsukK.V.KowdleyV.A.LuketicThe predictors of the presence of varices in patients with primary sclerosing cholangitisHepatology (Baltimore, Md).51201013021310
- E.GianniniF.BottaP.BorroPlatelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosisGut52200312001205
- A.AghaE.AnwarK.BashirV.SavarinoE.G.GianniniExternal validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosisDigest Dis Sci542009654660
- S.EsmatD.OmarnL.RashidCan we consider the right hepatic lobe size/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients?Eur J Intern Med232012267272
- M.A.Abu El MakaremM.E.ShatatY.ShakerPlatelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: the special Egyptian situation: noninvasive prediction of esophageal varicesHepatitis Monthly112011278284
- Monkez M.Yousif HAEMohamed O.WahbaAsmaa M.EshInsulin resistance as a non invasive parameter for prediction of esophageal varices in patients with hepatitis C virus cirrhosisZUMJ202014
- T.AlempijevicV.BulatS.DjuranovicRight liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertensionWorld J Gastroenterol13200753315335
- A.El RayM.M.AzabI.M.A.El-AzizNon-invasive predictors for the presence, grade and risk of bleeding from esophageal varices in patients with post-hepatitic cirrhosisJ Egypt Soc Parasitol452015421428
- T.A.WynnL.BarronMacrophages: master regulators of inflammation and fibrosisSemin Liver Dis302010245257
- H.J.MollerN.A.PeterslundJ.H.GraversenS.K.MoestrupIdentification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasmaBlood992002378380
- S.Rodgaard-HansenA.RafiqueP.A.ChristensenA soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illnessClin Chem Lab Med522014453461
- U.GaziM.RosasS.SinghFungal recognition enhances mannose receptor shedding through dectin-1 engagementJ Biol Chem286201178227829
- K.A.HintzA.J.RassiasK.WardwellEndotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163J Leukocyte Biol722002711717
- Y.Y.YangM.C.HouM.W.LinCombined platelet count with sCD163 and genetic variants optimizes esophageal varices prediction in cirrhotic patientsJ Gastroenterol Hepatol282013112121
- H.GronbaekT.D.SandahlC.MortensenH.VilstrupH.J.MollerS.MollerSoluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosisAliment Pharm Therap362012173180
- O.WaidmannF.BrunnerE.HerrmannS.ZeuzemA.PiiperB.KronenbergerMacrophage activation is a prognostic parameter for variceal bleeding and overall survival in patients with liver cirrhosisJ Hepatol582013956961